1. Market Research
  2. > Healthcare
  3. > Pathology
  4. > Cancer Market Trends
  5. > Oncology - 30 GLOBAL COMPANIES PROFILES

Oncology - 30 GLOBAL COMPANIES PROFILES

  • May 2015
  • -
  • Expernova
  • -
  • 141 pages

Find in this report 30 profiles of innovative companies that are part of the global expertise on Oncology.



Cancer is a pathology characterized by uncontrolled and cellular proliferation which causes the death of millions of people worldwide every year. Lifestyles, aging, population growth and rising treatment costs, are new challenges for the fight against cancer. Lifestyle (diet and smoking), exposure to carcinogens, and hereditary factors are the main causes of cancer, amongst which the most commonly diagnosed are lung, breast, and colorectal cancer.
With almost 22 million new annual cases expected in 2030, it is essential that the domain of oncology evolves and develops. The needs of patients in oncology change requiring this special branch of medical study, diagnostic and therapeutic management to reflect on new diagnostic and therapeutic approaches. Thanks to promising, innovative treatments and new therapies, we are already observing undeniable advances which have a real impact on the chances of survival.
The experts in oncology are looking toward a future focused on personalized medicine, out-patient care and successful methods of cured patients. The development of techniques for mini or non-invasive procedures and high-definition scanners dedicated to patients, are also major topics for future development.



Featuring 30 companies’ profiles such as Novartis International and Sanofi Aventis, this report is ideal for anyone wanting:



- Identify R&D Partners,



- Obtain IP & Technologic Intelligence,



- Develop your R&D Partnerships,



- And also benchmark competitors.



…all on a global scale.



These Key Innovation Leaders are based in Europe (France, Germany…).





For each of them, you will receive a scientific profile updated at time of order, a selection of focused works and a presentation of their collaborative partners, as well as an in-depth explanation of why they are leaders on Oncology.



Here are some examples of our data sources:



Research institutes databases (NASA, MIT, Fraunhofer, ...)



Patent Databases (European Patent Office, USPTO, ...)



Thematic Databases (MedLine/PubMed, INRA, ...)



Project Databases (Cordis FP-7, FP-6, ...)



Profile packs are generated and updated with the unique mapping technology developed by Expernova. Expernova data base is constantly growing, so each profile pack updated at any given time is potentially different from the others profile packs generated at other times on the same subject.



SCOPE OF THE REPORT

medical oncology, radiation oncology, pharmaceutical composition, clinical trial, malignant tumor, pediatric oncology, cancer, radiation therapy, antineoplastic agent, oncological disease, oncology nursing, gynecologic oncology


Table Of Contents

Oncology - 30 GLOBAL COMPANIES PROFILES

I. Selection of key-profiles of innovative companies

1. Companies profiles


APPENDIX

- Companies Index

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Veronica

+1 718 514 2762

Purchase Reports From Reputable Market Research Publishers
Hematological Cancers: Analytical Tool

Hematological Cancers: Analytical Tool

  • $ 11505
  • Industry report
  • August 2016
  • by Bioseeker

Analytical Tools are cancer area specific intelligence and surveillance toolkits within a select number of hot, emerging cancer therapy areas. They are designed to empower biotech/pharma professionals ...

Frontier Pharma: Glioblastoma Multiforme - Cancer Immunotherapies Dominate First-in-Class Product Innovation

Frontier Pharma: Glioblastoma Multiforme - Cancer Immunotherapies Dominate First-in-Class Product Innovation

  • $ 6995
  • Industry report
  • September 2016
  • by GBI Research

Frontier Pharma: Glioblastoma Multiforme - Cancer Immunotherapies Dominate First-in-Class Product Innovation Summary Glioblastoma multiforme (GBM) is a grade IV tumor that arises from astrocytes. It is ...

Lung Cancer: Analytical Tool

Lung Cancer: Analytical Tool

  • $ 8096
  • Industry report
  • August 2016
  • by Bioseeker

Analytical Tools are cancer area specific intelligence and surveillance toolkits within a select number of hot, emerging cancer therapy areas. They are designed to empower biotech/pharma professionals ...

Ovarian Cancer: Analytical Tool

August 2016 $ 8096

Renal Cancer: Analytical Tool

August 2016 $ 8096

Bladder Cancer: Analytical Tool

August 2016 $ 8096

Brain Cancer: Analytical Tool

August 2016 $ 8096

Breast Cancer: Analytical Tool

August 2016 $ 8096

Download Unlimited Documents from Trusted Public Sources

Therapy and Hormone Market in South Korea

  • December 2016
    4 pages
  • Therapy  

    Hormone  

    Cancer  

  • South Korea  

View report >

Cancer Statistics in the UK

  • December 2016
    20 pages
  • Cancer  

  • United Kingdom  

    Europe  

View report >

Cancer Statistics in the US and South Korea

  • November 2016
    2 pages
  • Cancer  

  • United States  

    South Korea  

View report >

Related Market Segments :

Cancer
Oncology

ref:plp2015

Reportlinker.com © Copyright 2016. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.